Results 81 to 90 of about 1,591,356 (281)

Healthcare financing in OECD countries beyond the public-private split [PDF]

open access: yes
Background: Studies of long-term trends in the healthcare financing mix generally focus on a dichotomous concept discerning public from private funding sources. More detailed analyses of the funding mix tend to be restricted to a small number of cases or
Schmid, Achim, Götze, Ralf
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Who pays for healthcare in Bangladesh? An analysis of progressivity in health systems financing

open access: yesInternational Journal for Equity in Health, 2017
Background The relationship between payments towards healthcare and ability to pay is a measure of financial fairness. Analysis of progressivity is important from an equity perspective as well as for macroeconomic and political analysis of healthcare ...
Azaher Ali Molla, Chunhuei Chi
doaj   +1 more source

Public financing of healthcare services [PDF]

open access: yes, 2013
Healthcare in Poland is mainly financed by public sector entities, among them the National Health Fund (NFZ), state budget and local government budgets. The task of the National Health Fund, as the main payer in the system, is chiefly currently financing
Bem, Agnieszka
core   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Distress financing on inpatient health expenditure across States in India

open access: yesBMC Health Services Research
Background Out-of-pocket (OOP) healthcare expenditures remain a significant burden and are a leading cause of distress financing, particularly among socioeconomically disadvantaged households in India.
Kamlesh Meena, Sanatan Nayak
doaj   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Fairness in healthcare financing and catastrophic expenditure in India

open access: yesDiscover Public Health
Achieving equity in healthcare financing remains a major policy challenge in developing economies where households rely heavily on out-of-pocket (OOP) payments to access healthcare services.
Piya Ghosh, Jayanta Sen
doaj   +1 more source

Sustainability of healthcare financing in the Western Balkans : an overview of progress and challenges [PDF]

open access: yes
This paper explores the major challenges to the sustainability of health sector financing in the countries of the Western Balkans - Albania, Bosnia and Herzegovina, the Former Yugoslav Republic of Macedonia, Montenegro, Serbia and the province of Kosovo.
Bredenkamp, Caryn, Gragnolati, Michele
core  

St. Vincent's Healthcare Group annual review 2004 [PDF]

open access: yes, 2005
St.
St. Vincent's Healthcare Group Ltd.
core  

Home - About - Disclaimer - Privacy